QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)
QQQ   354.65 (+0.75%)
AAPL   180.95 (+0.48%)
MSFT   335.40 (+0.85%)
META   272.61 (+0.00%)
GOOGL   124.67 (+0.77%)
AMZN   124.25 (+1.21%)
TSLA   213.97 (+3.11%)
NVDA   393.27 (-1.11%)
NIO   7.56 (+0.27%)
BABA   84.26 (+1.52%)
AMD   117.86 (-1.35%)
T   15.21 (-3.86%)
F   12.38 (+2.23%)
MU   69.17 (+0.12%)
CGC   0.83 (-1.20%)
GE   105.79 (+1.07%)
DIS   90.77 (+2.46%)
AMC   4.56 (+0.00%)
PFE   38.35 (+0.87%)
PYPL   63.96 (+1.44%)
NFLX   400.47 (-0.66%)

Humana (HUM) Competitors

$520.78
+5.63 (+1.09%)
(As of 06/2/2023 ET)
Compare
Today's Range
$512.56
$523.01
50-Day Range
$483.41
$535.96
52-Week Range
$418.70
$571.30
Volume
768,021 shs
Average Volume
983,903 shs
Market Capitalization
$65.07 billion
P/E Ratio
21.15
Dividend Yield
0.68%
Price Target
$599.72

HUM vs. CNC, ELV, MOH, BDX, GSK, BSX, MCK, HCA, TAK, and EW

Should you be buying Humana stock or one of its competitors? The main competitors of Humana include Centene (CNC), Elevance Health (ELV), Molina Healthcare (MOH), Becton, Dickinson and (BDX), GSK (GSK), Boston Scientific (BSX), McKesson (MCK), HCA Healthcare (HCA), Takeda Pharmaceutical (TAK), and Edwards Lifesciences (EW). These companies are all part of the "medical" sector.

Humana vs.

Centene (NYSE:CNC) and Humana (NYSE:HUM) are both large-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, media sentiment, institutional ownership, community ranking, risk, valuation, earnings and dividends.

Centene has a beta of 0.56, indicating that its share price is 44% less volatile than the S&P 500. Comparatively, Humana has a beta of 0.72, indicating that its share price is 28% less volatile than the S&P 500.

In the previous week, Humana had 4 more articles in the media than Centene. MarketBeat recorded 12 mentions for Humana and 8 mentions for Centene. Centene's average media sentiment score of 0.50 beat Humana's score of 0.04 indicating that Centene is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Centene
3 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Humana
2 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
2 Negative mention(s)
1 Very Negative mention(s)
Neutral

Humana has a net margin of 3.26% compared to Centene's net margin of 1.01%. Humana's return on equity of 21.04% beat Centene's return on equity.

Company Net Margins Return on Equity Return on Assets
Centene 1.01% 13.61% 4.28%
Humana 3.26% 21.04% 6.87%

93.3% of Centene shares are owned by institutional investors. Comparatively, 93.4% of Humana shares are owned by institutional investors. 0.3% of Centene shares are owned by insiders. Comparatively, 0.3% of Humana shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Humana has lower revenue, but higher earnings than Centene. Humana is trading at a lower price-to-earnings ratio than Centene, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Centene$144.55 billion0.25$1.20 billion$2.6425.17
Humana$92.87 billion0.70$2.81 billion$24.6221.15

Centene presently has a consensus target price of $91.11, suggesting a potential upside of 37.09%. Humana has a consensus target price of $599.72, suggesting a potential upside of 15.16%. Given Centene's higher possible upside, analysts plainly believe Centene is more favorable than Humana.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Centene
1 Sell rating(s)
5 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.59
Humana
0 Sell rating(s)
1 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.93

Centene received 141 more outperform votes than Humana when rated by MarketBeat users. Likewise, 73.72% of users gave Centene an outperform vote while only 64.69% of users gave Humana an outperform vote.

CompanyUnderperformOutperform
CenteneOutperform Votes
993
73.72%
Underperform Votes
354
26.28%
HumanaOutperform Votes
852
64.69%
Underperform Votes
465
35.31%

Summary

Humana beats Centene on 11 of the 18 factors compared between the two stocks.


New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HUM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HUM vs. The Competition

MetricHumanaHospital & medical service plans IndustryMedical SectorNYSE Exchange
Market Cap$65.07B$70.47B$4.56B$14.94B
Dividend Yield0.71%1.35%2.42%4.11%
P/E Ratio21.1514.71103.0818.51
Price / Sales0.700.593,554.139.04
Price / Cash15.6812.3890.6423.01
Price / Book3.913.215.219.28
Net Income$2.81B$3.18B$117.62M$902.66M
7 Day Performance4.87%3.27%1.77%2.53%
1 Month Performance-2.30%-2.03%3.72%2.68%
1 Year Performance15.84%-21.00%21.97%-8.54%

Humana Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CNC
Centene
3.2537 of 5 stars
$61.98
-1.2%
$91.11
+47.0%
-20.0%$34.01B$144.55B23.4874,300
ELV
Elevance Health
3.2875 of 5 stars
$441.60
-1.0%
$570.60
+29.2%
-7.0%$104.69B$156.60B17.18102,300Analyst Revision
News Coverage
MOH
Molina Healthcare
2.4892 of 5 stars
$269.78
-1.2%
$354.75
+31.5%
-1.5%$15.73B$31.97B18.3815,000
BDX
Becton, Dickinson and
2.6214 of 5 stars
$238.31
-1.2%
$276.60
+16.1%
-1.3%$67.68B$18.87B44.7177,000
GSK
GSK
2.3381 of 5 stars
$33.86
-1.1%
N/A-21.5%$69.33B$36.28B4.0969,400Short Interest ↓
BSX
Boston Scientific
2.6292 of 5 stars
$50.49
-1.1%
$53.89
+6.7%
+29.0%$70.69B$12.68B85.5845,000Analyst Report
MCK
McKesson
2.8057 of 5 stars
$384.37
-0.9%
$430.17
+11.9%
+20.8%$52.12B$276.71B15.3151,000Insider Selling
HCA
HCA Healthcare
2.5111 of 5 stars
$264.22
-0.1%
$298.17
+12.8%
+29.4%$72.71B$60.23B13.25294,000
TAK
Takeda Pharmaceutical
2.1837 of 5 stars
$16.08
-0.1%
$24.67
+53.4%
+12.1%$50.89B$4.03T20.8847,347
EW
Edwards Lifesciences
2.2993 of 5 stars
$81.42
-0.7%
$89.63
+10.1%
-12.5%$49.36B$5.38B33.7817,300Analyst Report
Insider Selling
Short Interest ↑

Related Companies and Tools

This page (NYSE:HUM) was last updated on 6/2/2023 by MarketBeat.com Staff

My Account -